19
PE Response Team Pavan Thangudu, MD San Antonio Advanced Lung Symposium December 7, 2019 1 2019 SAN ANTONIO ADVANCED LUNG SYMPOSIUM PE Response Team: What is Our Why? Pavan K Thangudu, MD ICU Co‐Director of Methodist Hospital Methodist Hospital PERT Team Leader 2019 SAN ANTONIO ADVANCED LUNG SYMPOSIUM Disclosure Nothing to disclose 2019 SAN ANTONIO ADVANCED LUNG SYMPOSIUM 2019 SAN ANTONIO ADVANCED LUNG SYMPOSIUM 2019 SAN ANTONIO ADVANCED LUNG SYMPOSIUM 2019 SAN ANTONIO ADVANCED LUNG SYMPOSIUM 1 2 3 4 5 6

2019SAN ANTONIO ADVANCED LUNG SYMPOSIUM Disclosure PE ... · Sub‐Massive PE vs Massive PE •Pulmonary Embolism •RV dysfunction •RV/LV >0.9 ... •Multidisciplinary Team approach

  • Upload
    others

  • View
    1

  • Download
    0

Embed Size (px)

Citation preview

Page 1: 2019SAN ANTONIO ADVANCED LUNG SYMPOSIUM Disclosure PE ... · Sub‐Massive PE vs Massive PE •Pulmonary Embolism •RV dysfunction •RV/LV >0.9 ... •Multidisciplinary Team approach

PE Response TeamPavan Thangudu, MD

San Antonio Advanced Lung SymposiumDecember 7, 2019

1

2 0 1 9 S A N   A N T O N I O   A D V A N C E D   L U N G   S Y M P O S I U M

PE Response Team: What is Our Why?Pavan K Thangudu, MD

ICU Co‐Director  of Methodist Hospital

Methodist Hospital PERT Team Leader

2 0 1 9 S A N   A N T O N I O   A D V A N C E D   L U N G   S Y M P O S I U M

Disclosure• Nothing to disclose

2 0 1 9 S A N   A N T O N I O   A D V A N C E D   L U N G   S Y M P O S I U M 2 0 1 9 S A N   A N T O N I O   A D V A N C E D   L U N G   S Y M P O S I U M

2 0 1 9 S A N   A N T O N I O   A D V A N C E D   L U N G   S Y M P O S I U M 2 0 1 9 S A N   A N T O N I O   A D V A N C E D   L U N G   S Y M P O S I U M

1 2

3 4

5 6

Page 2: 2019SAN ANTONIO ADVANCED LUNG SYMPOSIUM Disclosure PE ... · Sub‐Massive PE vs Massive PE •Pulmonary Embolism •RV dysfunction •RV/LV >0.9 ... •Multidisciplinary Team approach

PE Response TeamPavan Thangudu, MD

San Antonio Advanced Lung SymposiumDecember 7, 2019

2

2 0 1 9 S A N   A N T O N I O   A D V A N C E D   L U N G   S Y M P O S I U M

22 M

HR 129

BP: 130/67

SHOCK INDEX < 1

(HR/SBP)

•TroponinI: 0.05•BNP: 494•Lactic:1.9

2 0 1 9 S A N   A N T O N I O   A D V A N C E D   L U N G   S Y M P O S I U M

Anticoagulation Systemic Thrombolysis

ThrombectomyCatheter Directed Thrombolysis

How Should we Proceed? 

2 0 1 9 S A N   A N T O N I O   A D V A N C E D   L U N G   S Y M P O S I U M

Surgical Thrombectomy

2 0 1 9 S A N   A N T O N I O   A D V A N C E D   L U N G   S Y M P O S I U M

Surgical Thrombectomy

2 0 1 9 S A N   A N T O N I O   A D V A N C E D   L U N G   S Y M P O S I U M

Sub‐Massive PE            vs               Massive PE

• Pulmonary Embolism

• RV dysfunction• RV/LV > 0.9 

• CT• ECHO

• Elevated tnI• Elevated BNP

• Pulmonary Embolism

•RV failure• SHOCK• Lactic > 2• Vasopressors• Inotropes• SBP < 90• Cardiac Arrest• Syncope

2 0 1 9 S A N   A N T O N I O   A D V A N C E D   L U N G   S Y M P O S I U M

High Risk Pulmonary Emboli

Sub‐Massive 

PEHemodynamic Instability

Massive PE

Death

RV DysfunctionMortality of 25%

RV FAILURE

Mortality of 58%

7 8

9 10

11 12

Page 3: 2019SAN ANTONIO ADVANCED LUNG SYMPOSIUM Disclosure PE ... · Sub‐Massive PE vs Massive PE •Pulmonary Embolism •RV dysfunction •RV/LV >0.9 ... •Multidisciplinary Team approach

PE Response TeamPavan Thangudu, MD

San Antonio Advanced Lung SymposiumDecember 7, 2019

3

2 0 1 9 S A N   A N T O N I O   A D V A N C E D   L U N G   S Y M P O S I U M

Sub‐Massive PE

Massive PE Death

Which do we Treat? 

The Clot  The Right Ventricle

2 0 1 9 S A N   A N T O N I O   A D V A N C E D   L U N G   S Y M P O S I U M

2 0 1 9 S A N   A N T O N I O   A D V A N C E D   L U N G   S Y M P O S I U M 2 0 1 9 S A N   A N T O N I O   A D V A N C E D   L U N G   S Y M P O S I U M

2 0 1 9 S A N   A N T O N I O   A D V A N C E D   L U N G   S Y M P O S I U M 2 0 1 9 S A N   A N T O N I O   A D V A N C E D   L U N G   S Y M P O S I U M

13 14

15 16

17 18

Page 4: 2019SAN ANTONIO ADVANCED LUNG SYMPOSIUM Disclosure PE ... · Sub‐Massive PE vs Massive PE •Pulmonary Embolism •RV dysfunction •RV/LV >0.9 ... •Multidisciplinary Team approach

PE Response TeamPavan Thangudu, MD

San Antonio Advanced Lung SymposiumDecember 7, 2019

4

2 0 1 9 S A N   A N T O N I O   A D V A N C E D   L U N G   S Y M P O S I U M

22 M

HR 129

BP: 130/67

SHOCK INDEX < 1

•TroponinI: 0.05•BNP: 494•Lactic:1.9

2 0 1 9 S A N   A N T O N I O   A D V A N C E D   L U N G   S Y M P O S I U M

Anticoagulation Systemic Thrombolysis

ThrombectomyCatheter Directed Thrombolysis

How Should we Proceed? 

2 0 1 9 S A N   A N T O N I O   A D V A N C E D   L U N G   S Y M P O S I U M 2 0 1 9 S A N   A N T O N I O   A D V A N C E D   L U N G   S Y M P O S I U M

Surgical Thrombectomy

2 0 1 9 S A N   A N T O N I O   A D V A N C E D   L U N G   S Y M P O S I U M

Case 1

Patient underwent emergent EKOS

RIJ EKOS approach with 6h dose with concomitant heparin gtt

Bridged to apixaban

Discharged home on room air. 

No complications. 

2 0 1 9 S A N   A N T O N I O   A D V A N C E D   L U N G   S Y M P O S I U M

1.47

1.090.5

1

1.5

2

Baseline 48 Hour

RV/LV Ratio

Cohort 124% Reduction in RV/LV Ratio

2 (h) EKOS™ Duration  |  4/8 mg r‐tPA*

P<0.0001

1.431.09

0.5

1

1.5

2

Baseline 48 Hour

RV/LV Ratio

Cohort 223% Reduction in RV/LV Ratio

4 (h) EKOS ™ Duration  |  4/8 mg r‐tPA*

P<0.0001

1.49

1.090.5

1

1.5

2

Baseline 48 Hour

RV/LV Ratio

Cohort 326% Reduction in RV/LV Ratio

6 (h) EKOS ™ Duration  |  6/12 mg r‐tPA*

P<0.0001

1.51

1.030.5

1

1.5

2

Baseline 48 Hour

RV/LV Ratio

Cohort 426% Reduction in RV/LV Ratio

6 (h) EKOS ™ Duration  |  12/24 mg r‐tPA*

P<0.0005

Tapson V et al., American Thoracic Society (ATS) meeting, Washington, DC, May 2017.

*Total mg r-tPA: one/two catheters

All OPTALYSE PE cohorts showed significant reduction in RV/LV at 48 hours post‐initiation of procedure

19 20

21 22

23 24

Page 5: 2019SAN ANTONIO ADVANCED LUNG SYMPOSIUM Disclosure PE ... · Sub‐Massive PE vs Massive PE •Pulmonary Embolism •RV dysfunction •RV/LV >0.9 ... •Multidisciplinary Team approach

PE Response TeamPavan Thangudu, MD

San Antonio Advanced Lung SymposiumDecember 7, 2019

5

2 0 1 9 S A N   A N T O N I O   A D V A N C E D   L U N G   S Y M P O S I U M

Optalyse PE

Each of the OPTALYSE two‐, four‐, and six‐hour cohorts reduced RV/LV ratio by 23–26%:

• With tPA doses as low as 4 mgs. per catheter 

• With a very low bleeding rate

• Our dose of EKOS varies based off discussion with the intensivist and Interventional Radiologist and varies between 4h – 24h via RIJ approach. 

2 0 1 9 S A N   A N T O N I O   A D V A N C E D   L U N G   S Y M P O S I U M

2 0 1 9 S A N   A N T O N I O   A D V A N C E D   L U N G   S Y M P O S I U M 2 0 1 9 S A N   A N T O N I O   A D V A N C E D   L U N G   S Y M P O S I U M

2 0 1 9 S A N   A N T O N I O   A D V A N C E D   L U N G   S Y M P O S I U M 2 0 1 9 S A N   A N T O N I O   A D V A N C E D   L U N G   S Y M P O S I U M

50 MHR 120BP: 164/89O2: 80% on RASHOCK INDEX < 1(HR/SBP)

•Troponin I: 0.14•BNP: 29•Lactic:0.91

25 26

27 28

29 30

Page 6: 2019SAN ANTONIO ADVANCED LUNG SYMPOSIUM Disclosure PE ... · Sub‐Massive PE vs Massive PE •Pulmonary Embolism •RV dysfunction •RV/LV >0.9 ... •Multidisciplinary Team approach

PE Response TeamPavan Thangudu, MD

San Antonio Advanced Lung SymposiumDecember 7, 2019

6

2 0 1 9 S A N   A N T O N I O   A D V A N C E D   L U N G   S Y M P O S I U M

Anticoagulation Systemic Thrombolysis

ThrombectomyCatheter Directed Thrombolysis

How Should we Proceed? 

2 0 1 9 S A N   A N T O N I O   A D V A N C E D   L U N G   S Y M P O S I U M

High Risk Pulmonary Emboli

Sub‐Massive 

PEHemodynamic Instability

Massive PE

Death

RV DysfunctionMortality of 25%

RV FAILURE

Mortality of 58%

2 0 1 9 S A N   A N T O N I O   A D V A N C E D   L U N G   S Y M P O S I U M

Sub‐Massive PE

Massive PE Death

Which do we Treat? 

The Clot  The Right Ventricle

2 0 1 9 S A N   A N T O N I O   A D V A N C E D   L U N G   S Y M P O S I U M

WHY DOES MASSIVE PE KILL PATIENTS?

2 0 1 9 S A N   A N T O N I O   A D V A N C E D   L U N G   S Y M P O S I U M 2 0 1 9 S A N   A N T O N I O   A D V A N C E D   L U N G   S Y M P O S I U M

31 32

33 34

35 36

Page 7: 2019SAN ANTONIO ADVANCED LUNG SYMPOSIUM Disclosure PE ... · Sub‐Massive PE vs Massive PE •Pulmonary Embolism •RV dysfunction •RV/LV >0.9 ... •Multidisciplinary Team approach

PE Response TeamPavan Thangudu, MD

San Antonio Advanced Lung SymposiumDecember 7, 2019

7

2 0 1 9 S A N   A N T O N I O   A D V A N C E D   L U N G   S Y M P O S I U M 2 0 1 9 S A N   A N T O N I O   A D V A N C E D   L U N G   S Y M P O S I U M

2 0 1 9 S A N   A N T O N I O   A D V A N C E D   L U N G   S Y M P O S I U M

Sub‐Massive PE

Massive PE Death

Which do we Treat? 

The Clot  The Right Ventricle

2 0 1 9 S A N   A N T O N I O   A D V A N C E D   L U N G   S Y M P O S I U M

50 MHR 120BP: 164/89O2: 80% on RASHOCK INDEX < 1(HR/SBP)

•Troponin I: 0.14•BNP: 29•Lactic:0.91

2 0 1 9 S A N   A N T O N I O   A D V A N C E D   L U N G   S Y M P O S I U M 2 0 1 9 S A N   A N T O N I O   A D V A N C E D   L U N G   S Y M P O S I U M

37 38

39 40

41 42

Page 8: 2019SAN ANTONIO ADVANCED LUNG SYMPOSIUM Disclosure PE ... · Sub‐Massive PE vs Massive PE •Pulmonary Embolism •RV dysfunction •RV/LV >0.9 ... •Multidisciplinary Team approach

PE Response TeamPavan Thangudu, MD

San Antonio Advanced Lung SymposiumDecember 7, 2019

8

2 0 1 9 S A N   A N T O N I O   A D V A N C E D   L U N G   S Y M P O S I U M 2 0 1 9 S A N   A N T O N I O   A D V A N C E D   L U N G   S Y M P O S I U M

2 0 1 9 S A N   A N T O N I O   A D V A N C E D   L U N G   S Y M P O S I U M 2 0 1 9 S A N   A N T O N I O   A D V A N C E D   L U N G   S Y M P O S I U M

2 0 1 9 S A N   A N T O N I O   A D V A N C E D   L U N G   S Y M P O S I U M

AnticoagulationSystemic 

Thrombolysis

ThrombectomyCatheter Directed Thrombolysis

210‐575‐PERTMechanical Circulatory Support

Surgical Thrombectomy

2 0 1 9 S A N   A N T O N I O   A D V A N C E D   L U N G   S Y M P O S I U M

Systemic Thrombolysis VA ECMO

43 44

45 46

47 48

Page 9: 2019SAN ANTONIO ADVANCED LUNG SYMPOSIUM Disclosure PE ... · Sub‐Massive PE vs Massive PE •Pulmonary Embolism •RV dysfunction •RV/LV >0.9 ... •Multidisciplinary Team approach

PE Response TeamPavan Thangudu, MD

San Antonio Advanced Lung SymposiumDecember 7, 2019

9

2 0 1 9 S A N   A N T O N I O   A D V A N C E D   L U N G   S Y M P O S I U M 2 0 1 9 S A N   A N T O N I O   A D V A N C E D   L U N G   S Y M P O S I U M

tPA FAILS

2 0 1 9 S A N   A N T O N I O   A D V A N C E D   L U N G   S Y M P O S I U M 2 0 1 9 S A N   A N T O N I O   A D V A N C E D   L U N G   S Y M P O S I U M

tPA kills

60% 15%

8%

2 0 1 9 S A N   A N T O N I O   A D V A N C E D   L U N G   S Y M P O S I U M

EKOS won’t work

2 0 1 9 S A N   A N T O N I O   A D V A N C E D   L U N G   S Y M P O S I U M

EKOS EKOS

49 50

51 52

53 54

Page 10: 2019SAN ANTONIO ADVANCED LUNG SYMPOSIUM Disclosure PE ... · Sub‐Massive PE vs Massive PE •Pulmonary Embolism •RV dysfunction •RV/LV >0.9 ... •Multidisciplinary Team approach

PE Response TeamPavan Thangudu, MD

San Antonio Advanced Lung SymposiumDecember 7, 2019

10

2 0 1 9 S A N   A N T O N I O   A D V A N C E D   L U N G   S Y M P O S I U M 2 0 1 9 S A N   A N T O N I O   A D V A N C E D   L U N G   S Y M P O S I U M

2 0 1 9 S A N   A N T O N I O   A D V A N C E D   L U N G   S Y M P O S I U M

Previous investigations have estimated that about 50% of patients with massive PE died within 30 min, 70% within an hour and >85% died within 6 h from the symptom's onset [17].

2 0 1 9 S A N   A N T O N I O   A D V A N C E D   L U N G   S Y M P O S I U M

2 0 1 9 S A N   A N T O N I O   A D V A N C E D   L U N G   S Y M P O S I U M 2 0 1 9 S A N   A N T O N I O   A D V A N C E D   L U N G   S Y M P O S I U M

55 56

57 58

59 60

Page 11: 2019SAN ANTONIO ADVANCED LUNG SYMPOSIUM Disclosure PE ... · Sub‐Massive PE vs Massive PE •Pulmonary Embolism •RV dysfunction •RV/LV >0.9 ... •Multidisciplinary Team approach

PE Response TeamPavan Thangudu, MD

San Antonio Advanced Lung SymposiumDecember 7, 2019

11

2 0 1 9 S A N   A N T O N I O   A D V A N C E D   L U N G   S Y M P O S I U M

VAECMO

2 0 1 9 S A N   A N T O N I O   A D V A N C E D   L U N G   S Y M P O S I U M

• Right Ventricle Unloading• Fibrinolytic• Provides oxygenation support• Minimizes need for vasopressors and inotropes

• Minimizes need for Mechanical Ventilation

VAECMO

2 0 1 9 S A N   A N T O N I O   A D V A N C E D   L U N G   S Y M P O S I U M 2 0 1 9 S A N   A N T O N I O   A D V A N C E D   L U N G   S Y M P O S I U M

2 0 1 9 S A N   A N T O N I O   A D V A N C E D   L U N G   S Y M P O S I U M 2 0 1 9 S A N   A N T O N I O   A D V A N C E D   L U N G   S Y M P O S I U M

High Risk Pulmonary Emboli

Sub‐Massive 

PEHemodynamic Instability

Massive PE

Death

RV DysfunctionMortality of 25%

RV FAILURE

Mortality of 58%

61 62

63 64

65 66

Page 12: 2019SAN ANTONIO ADVANCED LUNG SYMPOSIUM Disclosure PE ... · Sub‐Massive PE vs Massive PE •Pulmonary Embolism •RV dysfunction •RV/LV >0.9 ... •Multidisciplinary Team approach

PE Response TeamPavan Thangudu, MD

San Antonio Advanced Lung SymposiumDecember 7, 2019

12

2 0 1 9 S A N   A N T O N I O   A D V A N C E D   L U N G   S Y M P O S I U M

Sub‐Massive PE

Massive PE Death

Which do we Treat? 

The Clot  The Right Ventricle

2 0 1 9 S A N   A N T O N I O   A D V A N C E D   L U N G   S Y M P O S I U M

2 0 1 9 S A N   A N T O N I O   A D V A N C E D   L U N G   S Y M P O S I U M 2 0 1 9 S A N   A N T O N I O   A D V A N C E D   L U N G   S Y M P O S I U M

2 0 1 9 S A N   A N T O N I O   A D V A N C E D   L U N G   S Y M P O S I U M 2 0 1 9 S A N   A N T O N I O   A D V A N C E D   L U N G   S Y M P O S I U M

50 MHR 120BP: 164/89O2: 80% on RASHOCK INDEX < 1

•Troponin I: 0.14•BNP: 29•Lactic:0.91

67 68

69 70

71 72

Page 13: 2019SAN ANTONIO ADVANCED LUNG SYMPOSIUM Disclosure PE ... · Sub‐Massive PE vs Massive PE •Pulmonary Embolism •RV dysfunction •RV/LV >0.9 ... •Multidisciplinary Team approach

PE Response TeamPavan Thangudu, MD

San Antonio Advanced Lung SymposiumDecember 7, 2019

13

2 0 1 9 S A N   A N T O N I O   A D V A N C E D   L U N G   S Y M P O S I U M 2 0 1 9 S A N   A N T O N I O   A D V A N C E D   L U N G   S Y M P O S I U M

2 0 1 9 S A N   A N T O N I O   A D V A N C E D   L U N G   S Y M P O S I U M

tpA VA ECMO

2 0 1 9 S A N   A N T O N I O   A D V A N C E D   L U N G   S Y M P O S I U M

Case 2 ABGs

post intubation 7.235 | 56 |50.4 on PRVC 24 | 450 |100% |5 O2 sat of 77%

While bagging patient: 7.338 | 35.2 | 48.2 with O2 sat of 81%

s/p 50mg tpA – 7.242 | 58.2 | 64 on PRVC 24 | 450 |100% |5 O2sat of 87%

2 0 1 9 S A N   A N T O N I O   A D V A N C E D   L U N G   S Y M P O S I U M 2 0 1 9 S A N   A N T O N I O   A D V A N C E D   L U N G   S Y M P O S I U M

Methodist PERT Structure

Referring Physician

Critical Care Team

Radiology

Cardiology MCS team Hospitalist

Administration

Patient Placement

NursingPharmacy

Marketing

73 74

75 76

77 78

Page 14: 2019SAN ANTONIO ADVANCED LUNG SYMPOSIUM Disclosure PE ... · Sub‐Massive PE vs Massive PE •Pulmonary Embolism •RV dysfunction •RV/LV >0.9 ... •Multidisciplinary Team approach

PE Response TeamPavan Thangudu, MD

San Antonio Advanced Lung SymposiumDecember 7, 2019

14

2 0 1 9 S A N   A N T O N I O   A D V A N C E D   L U N G   S Y M P O S I U M

Benefits of PERT

• Multidisciplinary Team approach to a complex treatment. 

• Immediate response with protocolized care. 

• Quarterly Meetings to discuss cases and thresholds

• Some data to indicate reduce length of ICU stay

• Less variation in treatment

• Follow up management with PERT clinic

2 0 1 9 S A N   A N T O N I O   A D V A N C E D   L U N G   S Y M P O S I U M

Our Outcomes

• Launched April 15, 2019

• 105 activations

• 14 Massive PE –• 11 VA ECMO activations, 8 cannulations (1 septic pulmonary emboli)

• ~30% EKOS for Sub‐massive PE. 

• 6 IVC filters

• 4 complicated anticoagulation strategies

• 4 Septic Pulmonary Emboli

2 0 1 9 S A N   A N T O N I O   A D V A N C E D   L U N G   S Y M P O S I U M

Methodist PERT Algorithm 

+PE diagnosis

210‐575‐PERT

YES NO

Sub‐massive PE 

appropriate for EKOS?

Intensivist places EKOS order 1,2

Pt to go to MSICU unless on advanced cardiac device

NO

Assess for home 

management4

No

Call 210‐575‐ECMO

Yes

ECMO therapy + Heparin gtt –NO LYTICS

Systemic tpA3

Yes

Sub‐massive PE Criteria for EKOS• clot within first or second branch of 

pulmonary artery• RV dysfunction on ECHO • RV/LV ratio > 0.9 on CT or ECHO• ctnI > 0.5 pg/mL• BNP >  90 pg/mL

Is PE Massive? SBP < 90, SaO2 < 90%Vasopressors, Cardiac 

arrest, Syncope Bradycardia, Lactate > 2, Syncope,

Shock Index >1

2 0 1 9 S A N   A N T O N I O   A D V A N C E D   L U N G   S Y M P O S I U M

IS THE PE MASSIVE?

• SHOCK INDEX > 1

• SBP < 90

• LACTATE > 2

• SYNCOPE 

• Cardiac Arrest

• Vasopressors/Inotropes

• SaO2 < 90% or INCREASING OXYGEN REQUIREMENT

2 0 1 9 S A N   A N T O N I O   A D V A N C E D   L U N G   S Y M P O S I U M

• 58 W 

• SYNCOPE x4

• HR 106/ BP 106

• SHOCK INDEX = 1

• Temp 94.7 

• Cool Extremities

• Platelets 124

• Bicarb 20

• Cr 1.29

• Lactate 4

• BNP 308

• Troponin 0.27

2 0 1 9 S A N   A N T O N I O   A D V A N C E D   L U N G   S Y M P O S I U M

79 80

81 82

83 84

Page 15: 2019SAN ANTONIO ADVANCED LUNG SYMPOSIUM Disclosure PE ... · Sub‐Massive PE vs Massive PE •Pulmonary Embolism •RV dysfunction •RV/LV >0.9 ... •Multidisciplinary Team approach

PE Response TeamPavan Thangudu, MD

San Antonio Advanced Lung SymposiumDecember 7, 2019

15

2 0 1 9 S A N   A N T O N I O   A D V A N C E D   L U N G   S Y M P O S I U M 2 0 1 9 S A N   A N T O N I O   A D V A N C E D   L U N G   S Y M P O S I U M

2 0 1 9 S A N   A N T O N I O   A D V A N C E D   L U N G   S Y M P O S I U M 2 0 1 9 S A N   A N T O N I O   A D V A N C E D   L U N G   S Y M P O S I U M

High Risk Pulmonary Emboli

Sub‐Massive 

PEHemodynamic Instability

Massive PE

Death

RV DysfunctionMortality of 25%

RV FAILURE

Mortality of 58%

2 0 1 9 S A N   A N T O N I O   A D V A N C E D   L U N G   S Y M P O S I U M

Sub‐Massive PE

Massive PE Death

Which do we Treat? 

The Clot  The Right Ventricle

2 0 1 9 S A N   A N T O N I O   A D V A N C E D   L U N G   S Y M P O S I U M

85 86

87 88

89 90

Page 16: 2019SAN ANTONIO ADVANCED LUNG SYMPOSIUM Disclosure PE ... · Sub‐Massive PE vs Massive PE •Pulmonary Embolism •RV dysfunction •RV/LV >0.9 ... •Multidisciplinary Team approach

PE Response TeamPavan Thangudu, MD

San Antonio Advanced Lung SymposiumDecember 7, 2019

16

2 0 1 9 S A N   A N T O N I O   A D V A N C E D   L U N G   S Y M P O S I U M

AnticoagulationSystemic 

Thrombolysis

ThrombectomyCatheter Directed Thrombolysis

210‐575‐PERTMechanical Circulatory Support

2 0 1 9 S A N   A N T O N I O   A D V A N C E D   L U N G   S Y M P O S I U M

2 0 1 9 S A N   A N T O N I O   A D V A N C E D   L U N G   S Y M P O S I U M 2 0 1 9 S A N   A N T O N I O   A D V A N C E D   L U N G   S Y M P O S I U M

• 58 W 

• SYNCOPE x4

• HR 106/ BP 106

• SHOCK INDEX = 1

• Temp 94.7 

• Cool Extremities

• Platelets 124

• Bicarb 20

• Cr 1.29

• Lactate 4

• BNP 308

• Troponin 0.27

2 0 1 9 S A N   A N T O N I O   A D V A N C E D   L U N G   S Y M P O S I U M 2 0 1 9 S A N   A N T O N I O   A D V A N C E D   L U N G   S Y M P O S I U M

91 92

93 94

95 96

Page 17: 2019SAN ANTONIO ADVANCED LUNG SYMPOSIUM Disclosure PE ... · Sub‐Massive PE vs Massive PE •Pulmonary Embolism •RV dysfunction •RV/LV >0.9 ... •Multidisciplinary Team approach

PE Response TeamPavan Thangudu, MD

San Antonio Advanced Lung SymposiumDecember 7, 2019

17

2 0 1 9 S A N   A N T O N I O   A D V A N C E D   L U N G   S Y M P O S I U M 2 0 1 9 S A N   A N T O N I O   A D V A N C E D   L U N G   S Y M P O S I U M

2 0 1 9 S A N   A N T O N I O   A D V A N C E D   L U N G   S Y M P O S I U M

Previous investigations have estimated that about 50% of patients with massive PE died within 30 min, 70% within an hour and>85% died within 6 h from the symptom's onset [17].

2 0 1 9 S A N   A N T O N I O   A D V A N C E D   L U N G   S Y M P O S I U M

VAECMO

2 0 1 9 S A N   A N T O N I O   A D V A N C E D   L U N G   S Y M P O S I U M

• Right Ventricle Unloading• Fibrinolytic• Provides oxygenation support• Minimizes need for vasopressors and inotropes

• Minimizes need for Mechanical Ventilation

VAECMO

2 0 1 9 S A N   A N T O N I O   A D V A N C E D   L U N G   S Y M P O S I U M

97 98

99 100

101 102

Page 18: 2019SAN ANTONIO ADVANCED LUNG SYMPOSIUM Disclosure PE ... · Sub‐Massive PE vs Massive PE •Pulmonary Embolism •RV dysfunction •RV/LV >0.9 ... •Multidisciplinary Team approach

PE Response TeamPavan Thangudu, MD

San Antonio Advanced Lung SymposiumDecember 7, 2019

18

2 0 1 9 S A N   A N T O N I O   A D V A N C E D   L U N G   S Y M P O S I U M 2 0 1 9 S A N   A N T O N I O   A D V A N C E D   L U N G   S Y M P O S I U M

WHICH MORTALITY RATE would you offer your 

patient?60% or 5% Please call

210‐575‐PERT

2 0 1 9 S A N   A N T O N I O   A D V A N C E D   L U N G   S Y M P O S I U M

© 2017 Methodist Healthcare. Confidential: Contains proprietary information. Not intended for external distribution.

2 0 1 9 S A N   A N T O N I O   A D V A N C E D   L U N G   S Y M P O S I U M

2 0 1 9 S A N   A N T O N I O   A D V A N C E D   L U N G   S Y M P O S I U M 2 0 1 9 S A N   A N T O N I O   A D V A N C E D   L U N G   S Y M P O S I U M

103 104

105 106

107 108

Page 19: 2019SAN ANTONIO ADVANCED LUNG SYMPOSIUM Disclosure PE ... · Sub‐Massive PE vs Massive PE •Pulmonary Embolism •RV dysfunction •RV/LV >0.9 ... •Multidisciplinary Team approach

PE Response TeamPavan Thangudu, MD

San Antonio Advanced Lung SymposiumDecember 7, 2019

19

2 0 1 9 S A N   A N T O N I O   A D V A N C E D   L U N G   S Y M P O S I U M 2 0 1 9 S A N   A N T O N I O   A D V A N C E D   L U N G   S Y M P O S I U M

2 0 1 9 S A N   A N T O N I O   A D V A N C E D   L U N G   S Y M P O S I U M 2 0 1 9 S A N   A N T O N I O   A D V A N C E D   L U N G   S Y M P O S I U M

2 0 1 9 S A N   A N T O N I O   A D V A N C E D   L U N G   S Y M P O S I U M 2 0 1 9 S A N   A N T O N I O   A D V A N C E D   L U N G   S Y M P O S I U M

109 110

111 112

113 114